Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropinirole effects on metacognition and resting-state connectivity in healthy volunteers
2025-520800-81-00Phase 3Authorised
- Sponsor
- Università degli Studi di Modena e Reggio Emilia
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of ropinirole (2 arms), sponsored by Università degli Studi di Modena e Reggio Emilia. Primary endpoints: Within-participant change in metacognitive efficiency and Within-participant change in metacognitive bias. Planned start Dec 2025; status: authorised.
02
Drugs
ropinirole
Beyond the preview
Go deeper on 2025-520800-81-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-520800-81-00.